Since my last publication on LeMaitre Vascular, Inc. (NASDAQ: LMAT ) from June last year, the stock is +12% to the upside, with growth in both the capital and income accounts. I noted in the last report that "Equity strategist (US Equities)Technical focus on fundamental value drivers of business economics to uncover high probability long-term compounders. Seeking to buy at appropriate prices relative to intrinsic worth. Partners are represented over the cross-section of financial markets, from speculators, ...